FDA warns ‘Dr. Goodenowe’ health centre founder that his recent supplement study put patient health at risk
The U.S. Food and Drug Administration (FDA) has rebuked the founder of Moose Jaw, Sask.’s controversial Dr. Goodenowe Restorative Health Center, alleging that a recent clinical trial of his supplements put the safety and welfare of research subjects at risk.
The U.S. Food and Drug Administration (FDA) has rebuked the founder of Moose Jaw, Sask.’s controversial Dr. Goodenowe Restorative Health Center, alleging that a recent clinical trial of his supplements put the safety and welfare of research subjects at risk.
On Jan. 20, the FDA publicly posted a warning letter to Dayan Goodenowe and his company Prodrome Sciences USA, LLC, which manufactures pills and oils that he has claimed can help stop and reverse the progression of conditions like ALS, Alzheimer’s and autism.
The FDA says that between 2020 and 2021, Goodenowe enrolled 29 people in a clinical trial evaluating whether his product, ProdromeNeuro, was safe and tolerable for patients with mild to moderate dementia.
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.